Chloroquine for the Prevention or Treatment of COVID-19

Prior to the COVID-19 pandemic, chloroquine had a reputation as a relatively safe drug with a long history of usage and well understood safety profile.

Research

Pre-Pandemic Research

  • In 2005, researcher Martin Vincent and colleagues noted that chloroquine is a potent inhibitor of SARS coronavirus infection and spread.1)

Controversy

Cognitive Warfare

A document prepared by Innovation Hub for NATO describes an intentional deception surrounding chloroquine, perhaps even as a method of inflicting harm:

“As the example of COVID-19 shows, the massive amount of texts on the subject, including deliberately biased texts (example is the Lancet study on chloroquine) created an information and knowledge overload which, in turn, generates both a loss of credibility and a need for closure. Therefore the ability for humans to question, normally, any data/information presented is hampered, with a tendency to fall back on biases to the detriment of unfettered decision-making.”2)

1)
August 22, 2005 | Vincent et al | Virology Journal | doi: 10.1186/1743-422X-2-69
2)
du Cluzel, F., Cole, A., & le Guyader, H. (2020, November). Cognitive Warfare. Innovation Hub - ACT. Retrieved November 15, 2021, from https://www.innovationhub-act.org/sites/default/files/2021-01/20210122_CW%20Final.pdf
Back to top